Pulmonary arterial hypertension
|
0.500 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
Pulmonary arterial hypertension
|
0.500 |
GeneticVariation
|
disease |
CLINVAR |
|
|
|
Pulmonary arterial hypertension
|
0.500 |
Biomarker
|
disease |
HPO |
|
|
|
Pulmonary arterial hypertension
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Pulmonary arterial hypertension in scleroderma spectrum of disease was not associated with heterogeneous germline mutations of BMPR2.
|
12415595 |
2002 |
Pulmonary arterial hypertension
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
BMPR2 mutations in pulmonary arterial hypertension with congenital heart disease.
|
15358693 |
2004 |
Pulmonary arterial hypertension
|
0.500 |
Biomarker
|
disease |
BEFREE |
Bone morphogenetic protein receptor type II C-terminus interacts with c-Src: implication for a role in pulmonary arterial hypertension.
|
16002577 |
2005 |
Pulmonary arterial hypertension
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Mutations in the gene that codes for bone morphogenetic protein receptor type II (BMPR-II) are a major predisposition for the development of pulmonary arterial hypertension.
|
16121312 |
2005 |
Pulmonary arterial hypertension
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Mutations of the TGF-beta type II receptor BMPR2 in pulmonary arterial hypertension.
|
16429395 |
2006 |
Pulmonary arterial hypertension
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
These results support the hypothesis that loss-of-function mutations in BMPR2 could lead to increased pulmonary EC apoptosis, representing a possible initiating mechanism in the pathogenesis of pulmonary arterial hypertension.
|
16357305 |
2006 |
Pulmonary arterial hypertension
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Relationship of BMPR2 mutations to vasoreactivity in pulmonary arterial hypertension.
|
16717148 |
2006 |
Pulmonary arterial hypertension
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Our findings, taken in context with the observed prevalence of pulmonary arterial hypertension associated with BMPR2 mutations, define converging molecular pathways that lead to the development of pulmonary hypertension, through either genetic or epigenetic loss of function of components of the BMP signaling pathway.
|
16840720 |
2006 |
Pulmonary arterial hypertension
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
These results demonstrate that the 5'-untranslated region of BMPR2 is considerably longer than previously thought, emphasizing the need to fully characterize the BMPR2 promoter and the importance of analyzing noncoding regions in patients with pulmonary arterial hypertension who are negative for mutations within the coding region and intron-exon junctions.
|
17641158 |
2007 |
Pulmonary arterial hypertension
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Clinical outcomes of pulmonary arterial hypertension in carriers of BMPR2 mutation.
|
18356561 |
2008 |
Pulmonary arterial hypertension
|
0.500 |
Biomarker
|
disease |
BEFREE |
Implications of mutations of activin receptor-like kinase 1 gene (ALK1) in addition to bone morphogenetic protein receptor II gene (BMPR2) in children with pulmonary arterial hypertension.
|
18159113 |
2008 |
Pulmonary arterial hypertension
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Clinical implications of determining BMPR2 mutation status in a large cohort of children and adults with pulmonary arterial hypertension.
|
18503968 |
2008 |
Pulmonary arterial hypertension
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
BMPR2 mutation in a patient with pulmonary arterial hypertension and suspected hereditary hemorrhagic telangiectasia.
|
18792970 |
2008 |
Pulmonary arterial hypertension
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Copy-number variation in BMPR2 is not associated with the pathogenesis of pulmonary arterial hypertension.
|
19531247 |
2009 |
Pulmonary arterial hypertension
|
0.500 |
AlteredExpression
|
disease |
BEFREE |
Penetrance of pulmonary arterial hypertension is modulated by the expression of normal BMPR2 allele.
|
19206171 |
2009 |
Pulmonary arterial hypertension
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Novel promoter and exon mutations of the BMPR2 gene in Chinese patients with pulmonary arterial hypertension.
|
19223935 |
2009 |
Pulmonary arterial hypertension
|
0.500 |
AlteredExpression
|
disease |
BEFREE |
Furthermore, the recent finding that mutations in BMPR2 cause familial forms of pulmonary arterial hypertension and that BMPR2 expression is decreased in secondary forms of PH strongly implicate BMP signaling in the underlying pathophysiology of PH.
|
20347789 |
2010 |
Pulmonary arterial hypertension
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Absence of influence of gender and BMPR2 mutation type on clinical phenotypes of pulmonary arterial hypertension.
|
20534176 |
2010 |
Pulmonary arterial hypertension
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Whether the ET-1 cascade from non-vascular sources (inflammatory cells) also contributes to pulmonary artery hypertension (PAH) and in particular to heritable PAH (HPAH) with known bone morphogenetic protein type 2 receptor (BMPR2) mutations is not known.
|
20562228 |
2010 |
Pulmonary arterial hypertension
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Hemodynamic and clinical onset in patients with hereditary pulmonary arterial hypertension and BMPR2 mutations.
|
21801371 |
2011 |
Pulmonary arterial hypertension
|
0.500 |
Biomarker
|
disease |
BEFREE |
Connectivity map analysis of nonsense-mediated decay-positive BMPR2-related hereditary pulmonary arterial hypertension provides insights into disease penetrance.
|
22312021 |
2012 |
Pulmonary arterial hypertension
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
BMPR2 mutations influence phenotype more obviously in male patients with pulmonary arterial hypertension.
|
22923421 |
2012 |